Celldom Revenue and Competitors
Estimated Revenue & Valuation
- Celldom's estimated annual revenue is currently $2.3M per year.
- Celldom's estimated revenue per employee is $155,000
Employee Data
- Celldom has 15 Employees.
- Celldom grew their employee count by 15% last year.
Celldom's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
2 | Chief Technology Officer | Reveal Email/Phone |
3 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
4 | Director Live Cell Biology | Reveal Email/Phone |
5 | Director Single Cell Genomics | Reveal Email/Phone |
Celldom Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Celldom?
Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company's TrapTxâ„¢ Analyzer System uniquely integrates both phenotypic and genomic data at massive scale (up to 100,000s of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology and stem cell biology. Learn more at www.celldom.com and follow the company's growth @celldominc on Twitter.
keywords:N/AN/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.3M | 15 | 15% | N/A |
#2 | $3M | 15 | -21% | N/A |
#3 | $1.4M | 16 | 0% | N/A |
#4 | $1.5M | 17 | 6% | N/A |
#5 | $1.4M | 17 | 0% | N/A |